Medicine safety can be divided into the safety of a medicinal product and the safe use of a medicinal product.
The authorities supervise the safety, efficacy and quality of medicinal products before and after the product is released onto the market. Information on the safety of a medicinal product is collected, for example, through adverse reaction reports and studies. Safety information is particularly needed for new medicines. In fact, the package leaflets of new medicines often include a black triangle to show that the authorities wish to be notified of suspected adverse reactions in particular. Such medicines are referred to as medicinal products under additional monitoring.
Sometimes the medicine or its packaging does not meet the quality requirements, i.e. there is a product defect. The product defect may be related to the labelling or to the properties of the medicine. If you suspect a product defect in your medicine, contact the pharmacy as soon as possible. Medicine can also cause a medicine-related injury, for which you can seek compensation from Finnish Mutual Insurance Company for Pharmaceutical Injury Indemnities.
In addition to the desired effects, there is always a risk of adverse effects associated with the use of medicines. An interaction may follow if more than one medicine is used, i.e. medicines may prevent, strengthen or alter each other's effects. It is worth discussing the possible adverse reactions and interactions of your own medicines with a doctor and at the pharmacy. The package leaflet also contains further information.
Risk minimisation material has been prepared for some medicinal products to prevent risks associated with use. The material can include a guide aimed at patients, a diary or a monitoring form, for example.
If you are concerned about the safety of your medicine, discuss this with a doctor.